Board of Directors
Name | Position | Committee Membership | Year of Appointment |
---|---|---|---|
Peter Wilden | Chairman | Remuneration & Nomination Committee (member) | 2021 |
Patrick Aebischer | Vice Chairman, Lead Independent Director | Innovation & Technology Committee (chair) | 2021 |
Beat In-Albon | Independent Member | Audit & Risk Committee (chair) | 2021 |
Jane Salik | Member | Innovation and Technology Committee (member) | 2021 |
Erik Schropp | Member | Audit & Risk Committee (member) | 2021 |
Philippe Weber | Independent Member | Remuneration & Nomination Committee (chair) | 2021 |
Executive Committee
![]() Chief Executive Officer |
![]() Chief Financial Officer |
![]() Director Global Sales and Marketing |
![]() Director Global Operations |
![]() General Counsel |
Corporate Documents and Policies
Articles of Association
Organizational Regulations
Board Committee Charters
- Audit and Risk Committee
Download PDF - Remuneration and Nomination Committee
Download PDF - Innovation and Technology Committee
Download PDF
Internal Audit Charter
Code of Conduct
- For employees
Download PDF - For suppliers
Download PDF
Whistleblower Policy
- Whistleblower Policy – English
Download PDF - Whistleblower Policy – French
Download PDF - Whistleblower Policy – Swedish
Download PDF
Make Yourself Heard
At PolyPeptide we strive to remain focused on the needs of our customers and business, while adhering to fundamental principles of ethics and compliance. The foundation of our commitment is our Code of Conduct, which is mandatory for all employees across PolyPeptide.
Our managers have leadership responsibilities for setting a good example, encouraging an environment of open and honest communication without fear of retaliation, and taking prompt action when ethical or compliance issues are brought to their attention.
We also maintain a whistleblower program through which anybody with knowledge or suspicion of illegal activities or serious irregularities at PolyPeptide can report observations confidentially and even anonymously, if desired. Anyone who, in good faith, raises a concern about a possible ethics or compliance violation will be supported by PolyPeptide management and will not be subject to any form of retaliation. Issues we encourage to be reported include breaches of applicable laws and regulations like fraud, embezzlement, misuse of assets, forgery of documents, accounting manipulation, bribery, corruption, money laundering, competition law breaches, breaches of occupational health and safety legislation, infringements of environmental regulations and pollution of the environment and workplace conflicts such as severe bullying, harassment, discrimination, physical violence, threats and sexual abuse. To ensure confidentiality, PolyPeptide has mandated the operation of its whistleblower hotline to PwC. PwC is an independent audit, tax and advisory firm, which receives reports on behalf of PolyPeptide to ensure an independent channel for concerns. You can submit your report through the whistleblower hotline here.